ImmunityBio acquires biotech manufacturing facility in N.Y.
ImmunityBio has successfully acquired a leasehold interest in an International Organization for Standardization Class 5 pharmaceutical manufacturing space in western New York from global pharmaceutical company Athenex. The full-scale facility enables ImmunityBio to substantially expand and diversify its existing manufacturing capacity in the U.S. and through its strategic collaborators in Africa. Read More
Intellia, ONK Therapeutics advance CRISPR-edited NK cell therapies for cancer
Intellia Therapeutics and ONK Therapeutics have entered into a licensing and collaboration agreement to develop innovative cancer treatments by combining Intellia's CRISPR-based technologies with ONK's NK cell therapies. Read More
Trace Matters introduces Super Mass Spec and SPion Link technologies
Trace Matters Scientific has launched two new technologies -- Super Mass Spec and SPion Link -- both of which are mass spectrometry technologies enabling significant advancements in the scientific study of complex clinical samples, such as tissue and blood samples. Read More
Parse Biosciences raises $41.5M for single-cell sequencing products
Parse Biosciences has obtained $41.5 million in series B funding, bringing its total funding to date to over $50 million. Parse Biosciences is focused on providing scalable single-cell sequencing solutions. Read More
Thermo Fisher Scientific introduces commercial packaging, distribution services
Thermo Fisher Scientific has launched new integrated commercial packaging and distribution services. Patheon Commercial Packaging Services for Cell and Gene Therapies is an end-to-end solution combining the good manufacturing practices storage, serialization, ultracold and cryogenic packaging, and global distribution that developers need to support their logistics strategies. Read More
IASO Bio, Innovent CAR T-cell therapy receives orphan drug designation
IASO Biotherapeutics and Innovent Biologics jointly announced that the Office of Orphan Products Development at the U.S. Food and Drug Administration has granted orphan drug designation to their fully human, anti-B-cell maturation antigen, CAR T-cell therapy CT103A/IBI326 for the treatment of relapsed and/or refractory multiple myeloma. Read More
Eli Lilly's bebtelovimab receives EUA for mild-to-moderate COVID-19
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Eli Lilly's antibody bebtelovimab, which demonstrates neutralization against the omicron COVID-19 variant. Read More
TransCode Therapeutics expands global RNA oncology patent
TransCode Therapeutics has filed an international patent cooperation treaty (PCT) application (PCT/US21/65580) titled "Template Directed Immunomodulation for Cancer Therapy." This application is an extension of TransCode's patented RNA therapeutic platform to include using pattern recognition receptors to target tumor cells by activating the retinoic acid-inducible gene I signaling pathway. Read More
Avantor breaks ground on new distribution center
Avantor has started construction on a distribution center that will help expedite access to essential production materials for biopharmaceutical manufacturers in Ireland. The facility is expected to open later this year and will significantly increase distribution capacity to meet the growing demand for production materials by Ireland's biopharma industry, Avantor said. Read More
Pfizer, BioNTech provide update on COVID-19 vaccine
Pfizer and BioNTech extended their rolling submission to the U.S. Food and Drug Administration to amend the emergency use authorization of the Pfizer-BioNTech COVID-19 vaccine to include children six months old through four years of age. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
